{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:46:31Z","timestamp":1720140391105},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jpba.2016.02.027","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T22:50:58Z","timestamp":1456181458000},"page":"26-33","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development and validation of a highly sensitive LC\u2013MS\/MS-ESI method for quantification of IIIM-019\u2014A novel nitroimidazole derivative with promising action against Tuberculosis: Application to drug development"],"prefix":"10.1016","volume":"124","author":[{"given":"Gurleen","family":"Kour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal Krishan","family":"Chandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mowkshi","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurunadham","family":"Munagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvinder Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajai Prakash","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram A.","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zabeer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.02.027_bib0005","series-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jpba.2016.02.027_bib0010","series-title":"Multidrug and Extensively Drug Resistant TB (M\/XDR-TB): 2010 Global Report on Surveillance and Response 2010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.jpba.2016.02.027_bib0015","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/ajrccm.163.5.2007122","article-title":"The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps","volume":"163","author":"O\u2019Brien","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jpba.2016.02.027_bib0020","first-page":"663","article-title":"New initiative speeds tuberculosis drug development: novel drug regimens become possible in years, not decades","volume":"14","author":"Spigelman","year":"2010","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jpba.2016.02.027_bib0025","series-title":"Equity, Social Determinants and Public Health Programmes. World Health Organization Geneva, Switzerland","first-page":"221","article-title":"Tuberculosis: the role of risk factors and social determinants","author":"Lonnroth","year":"2010"},{"key":"10.1016\/j.jpba.2016.02.027_bib0030","series-title":"Treatment of Tuberculosis: Guidelines for National Programmes","author":"World Health Organization (WHO)","year":"2009"},{"key":"10.1016\/j.jpba.2016.02.027_bib0035","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.2174\/1381612043383214","article-title":"Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis","volume":"10","author":"Barry","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2016.02.027_bib0040","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/AAC.38.9.2054","article-title":"Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis","volume":"38","author":"Wayne","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2016.02.027_bib0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/jm00263a035","article-title":"New 5-substituted 1-alkyl-2-nitroimidazoles","volume":"16","author":"Cavalleri","year":"1973","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2016.02.027_bib0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0223-5234(89)90034-2","article-title":"Nitroimidazole XXI 2 3-dihtdro-6-nitroimidazo [2,1-b] oxazoles with antitubercular activity","volume":"24","author":"Nagarajan","year":"1989","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2016.02.027_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.37.2.183","article-title":"In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis","volume":"37","author":"Ashtekar","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2016.02.027_bib0060","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4155\/fmc.10.207","article-title":"The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies","volume":"2","author":"Denny","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jpba.2016.02.027_bib0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1371\/journal.pmed.0030466","article-title":"O.P.C.-67683, a nitro-dihydroimidazooxazole derivative with promising action against tuberculosis in vitro and in mice","volume":"3","author":"Matsumoto","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jpba.2016.02.027_bib0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40265-014-0241-5","article-title":"Delamanid: first global approval","volume":"74","author":"Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2016.02.027_bib0075","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/092986708785132906","article-title":"New anti-tuberculosis drugs with novel mechanisms of action","volume":"15","author":"Rivers","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2016.02.027_bib0080","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1021\/jm101288t","article-title":"Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy) benzyl]oxy}-6 7-dihydro-5himidazo[2,1-b][1,3]oxazine (PA-824)","volume":"53","author":"Kmentova","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2016.02.027_bib0085","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1039\/C5OB00054H","article-title":"Synthesis of new generation triazolyl- and isoxazolyl-containing 6-nitro-2, 3-dihydroimidazooxazoles as anti-TB agents: in vitro, structure-activity relationship, pharmacokinetics and in vivo evaluation","volume":"13","author":"Munagala","year":"2015","journal-title":"Org. Biomol Chem."},{"key":"10.1016\/j.jpba.2016.02.027_bib0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jchromb.2014.12.037","article-title":"Development and validation of an LC-MS\/MS method for the determination of pelubiprofen and its active metabolite, trans-alcohol, in human plasma and its application to pharmacokinetic study","volume":"983\u2013984","author":"Ryu","year":"2015","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2016.02.027_bib0095","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4236\/ajac.2012.312112","article-title":"Rapid LC-ESI\u2013MS\u2013MS method for the simultaneous determination of sitagliptin and pioglitazone in rat plasma and its application to pharmacokinetic study","volume":"3","author":"Samanthula","year":"2012","journal-title":"Am. J. Anal. Chem"},{"key":"10.1016\/j.jpba.2016.02.027_bib0100","series-title":"Guidance for Industry: Bioanalytical Method Validation","author":"US DHHS","year":"2001"},{"key":"10.1016\/j.jpba.2016.02.027_bib0105","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0","article-title":"The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds","volume":"13","author":"Bonfiglio","year":"1999","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2016.02.027_bib0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6446(01)01712-3","article-title":"Screening for human ADME\/TOX drug properties in drug discovery","volume":"6","author":"Li","year":"2001","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.jpba.2016.02.027_bib0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/dmd.104.000125","article-title":"Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations","volume":"32","author":"Jones","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2016.02.027_bib0120","series-title":"Principles and Methods of Toxicity","first-page":"77","article-title":"Metabolism: a determinant in toxicity","author":"deBethizy","year":"2001"},{"key":"10.1016\/j.jpba.2016.02.027_bib0125","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0076-6879(78)52008-9","article-title":"Preparation of microsomes with calcium","author":"Schenkman","year":"1978"},{"key":"10.1016\/j.jpba.2016.02.027_bib0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"Biol. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516300899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516300899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T21:56:20Z","timestamp":1654379780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708516300899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":26,"alternative-id":["S0731708516300899"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.02.027","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a highly sensitive LC\u2013MS\/MS-ESI method for quantification of IIIM-019\u2014A novel nitroimidazole derivative with promising action against Tuberculosis: Application to drug development","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}